Cargando…

P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN

Detalles Bibliográficos
Autores principales: Ramasamy, Karthik, Martin Kortum, K, Zhuleku, Evi, Zamagni, Elena, D’estrube, Tim, Shukla, Soham, Lehne, Moritz, Ghiani, Marco, Hanna, Maya, Maywald, Ulf, Wilke, Thomas, Kellermann, Lenka, Perera, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431391/
http://dx.doi.org/10.1097/01.HS9.0000970736.60138.57
_version_ 1785091189644460032
author Ramasamy, Karthik
Martin Kortum, K
Zhuleku, Evi
Zamagni, Elena
D’estrube, Tim
Shukla, Soham
Lehne, Moritz
Ghiani, Marco
Hanna, Maya
Maywald, Ulf
Wilke, Thomas
Kellermann, Lenka
Perera, Sue
author_facet Ramasamy, Karthik
Martin Kortum, K
Zhuleku, Evi
Zamagni, Elena
D’estrube, Tim
Shukla, Soham
Lehne, Moritz
Ghiani, Marco
Hanna, Maya
Maywald, Ulf
Wilke, Thomas
Kellermann, Lenka
Perera, Sue
author_sort Ramasamy, Karthik
collection PubMed
description
format Online
Article
Text
id pubmed-10431391
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104313912023-08-17 P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN Ramasamy, Karthik Martin Kortum, K Zhuleku, Evi Zamagni, Elena D’estrube, Tim Shukla, Soham Lehne, Moritz Ghiani, Marco Hanna, Maya Maywald, Ulf Wilke, Thomas Kellermann, Lenka Perera, Sue Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431391/ http://dx.doi.org/10.1097/01.HS9.0000970736.60138.57 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Ramasamy, Karthik
Martin Kortum, K
Zhuleku, Evi
Zamagni, Elena
D’estrube, Tim
Shukla, Soham
Lehne, Moritz
Ghiani, Marco
Hanna, Maya
Maywald, Ulf
Wilke, Thomas
Kellermann, Lenka
Perera, Sue
P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
title P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
title_full P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
title_fullStr P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
title_full_unstemmed P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
title_short P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
title_sort p958: real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in germany, italy, the uk, france, and spain
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431391/
http://dx.doi.org/10.1097/01.HS9.0000970736.60138.57
work_keys_str_mv AT ramasamykarthik p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT martinkortumk p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT zhulekuevi p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT zamagnielena p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT destrubetim p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT shuklasoham p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT lehnemoritz p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT ghianimarco p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT hannamaya p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT maywaldulf p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT wilkethomas p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT kellermannlenka p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain
AT pererasue p958realworldtreatmentpatternsinpatientsinitiatingthirdlinetherapyforrelapsedorrefractorymultiplemyelomaingermanyitalytheukfranceandspain